As early as 1997, Duong et al. [51], identified increased expression of CRP (since mCRP was not realized at this time), immunoreactivity within both plaques and neurofibrillary tangles (NFTs) of post‐mortem specimens from individuals who died with AD. The gene discussed is CRP; the disease is Alzheimer disease.